Tammam Hanna, MD, an orthopedic surgeon in Lubbock, Texas, performed the first U.S. clinical case of TYBR Health’s B3 Gel system, according to a Jan. 5 news release.
B3 Gel is a collagen-based tissue protector derived from extracellular matrix and conforms to the tissue surface.
“In a complex second-stage flexor tendon reconstruction—where balancing tissue protection with early rehabilitation is critical — I applied B3 GEL directly over the repair,” Dr. Hanna said in the release. “The gel set within minutes, maintained excellent visualization, and allowed smooth tendon gliding without restricting motion. I subsequently used it in two additional flexor tendon repair cases, and across these early cases I observed consistently favorable early range of motion, minimal stiffness, and no complications — findings that are very encouraging in this patient population.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
